Related Experiment Video
Updated: May 12, 2026

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
First report of ciprofloxacin-resistant Salmonella Enteritidis isolated from human cases in Morocco
Hajar Elmourabit1, Bouchra Karraouane2, Brahim Bouchrif2
1Laboratory of Plant Biotechnology, Faculty of Sciences, Ibn Zohr University, box 8106, Agadir, Morocco.
Introduction:
Salmonella enterica serovar Enteritidis is a principal cause of foodborne and invasive infections worldwide. Ciprofloxacin continues to be a primary treatment for invasive cases, but resistance has emerged in several regions. In Morocco, although S. Enteritidis is frequently isolated, no ciprofloxacin-resistant isolates have been reported to date.
Methodology:
A total of 60 Salmonella strains were detected in clinical samples from the Mohammed VI University Hospital Center in Marrakech between 2018 and 2024. Strain S54 was identified as S. Enteritidis by serotyping. Antimicrobial susceptibility testing was performed by disk diffusion. Whole-genome sequencing was conducted using Illumina technology, and resistance and virulence determinants were analyzed with ResFinder, PlasmidFinder, and VFDB databases.
Results:
Three isolates (5%), including the S54 strain, showed resistance to ciprofloxacin. Genomic analysis identified a D87Y substitution in gyrA and the presence of efflux genes (mdsA, mdsB). Several virulence genes, including those located in SPI-1 and SPI-2, were also detected.
Conclusions:
This study represents the first report of a ciprofloxacin-resistant S. Enteritidis strain in Morocco. These findings highlight the urgent need to strengthen molecular surveillance and implement preventive measures against fluoroquinolone-resistant Salmonella.
Insights
The first ciprofloxacin-resistant Salmonella Enteritidis strain was identified in Morocco. This finding underscores the need for enhanced surveillance of antimicrobial resistance in Salmonella to prevent further spread.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Salmonella Enteritidis is a major cause of global foodborne and invasive infections.
- Ciprofloxacin is a key treatment for invasive Salmonella, but resistance is a growing concern.
- No ciprofloxacin-resistant S. Enteritidis had been reported in Morocco prior to this study.
Purpose of the Study:
- To report the first instance of ciprofloxacin-resistant Salmonella Enteritidis in Morocco.
- To characterize the genetic basis of ciprofloxacin resistance in this isolate.
- To emphasize the need for improved surveillance of antimicrobial resistance.
Main Methods:
- Sixty Salmonella strains were isolated from clinical samples in Marrakech (2018-2024).
- Antimicrobial susceptibility testing (disk diffusion) and whole-genome sequencing were performed.
- Genomic analysis identified resistance and virulence genes using ResFinder, PlasmidFinder, and VFDB.
Main Results:
- Three isolates (5%), including strain S54, exhibited resistance to ciprofloxacin.
- Genomic analysis revealed a gyrA D87Y mutation and efflux genes (mdsA, mdsB).
- Virulence genes located in SPI-1 and SPI-2 were also detected.
Conclusions:
- This study documents the first ciprofloxacin-resistant S. Enteritidis strain identified in Morocco.
- The findings highlight the critical need for enhanced molecular surveillance.
- Preventive strategies against fluoroquinolone-resistant Salmonella are urgently required.
Related Concept Videos
Reservoir of Infection
Investigation of Disease Outbreaks
